PTPN22 and triple-A syndrome: Although the increased expression and diagnostic value of PTPN22 were verified using a peripheral blood sample-based cohort in this study, more PBMC-based examinations of PTPN22 between healthy controls and patients with AAA need be conducted to confirm its clinical value as a biomarker for AAA.